China Medical System Holdings (HKG:867) Could Easily Take On More Debt
Dec 09
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedDec 11, 2025
DataAggregated Company Financials
Companies43
- 7D1.9%
- 3M-6.1%
- 1Y65.9%
- YTDn/a
Last week, the Pharma industry hasn't moved much but Hansoh Pharmaceutical Group is up 5.8% in that time. As for the the longer term, the industry is up 67% over the past 12 months. Earnings are forecast to grow by 14% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 11 Dec 2025 | HK$828.9b | HK$484.9b | HK$29.7b | 13.5x | 27.9x | 1.7x |
| Sat, 08 Nov 2025 | HK$792.8b | HK$480.7b | HK$29.9b | 14x | 26.6x | 1.6x |
| Mon, 06 Oct 2025 | HK$816.5b | HK$479.6b | HK$30.6b | 13.7x | 26.7x | 1.7x |
| Wed, 03 Sep 2025 | HK$810.7b | HK$479.5b | HK$30.6b | 13.1x | 26.5x | 1.7x |
| Fri, 01 Aug 2025 | HK$760.0b | HK$474.3b | HK$29.0b | 12.2x | 26.2x | 1.6x |
| Sun, 29 Jun 2025 | HK$632.6b | HK$475.8b | HK$28.7b | 11.3x | 22x | 1.3x |
| Tue, 27 May 2025 | HK$556.4b | HK$477.6b | HK$28.8b | 10.8x | 19.3x | 1.2x |
| Thu, 24 Apr 2025 | HK$506.3b | HK$467.0b | HK$28.6b | 10.3x | 17.7x | 1.1x |
| Sat, 22 Mar 2025 | HK$470.9b | HK$466.2b | HK$32.0b | 9x | 14.7x | 1x |
| Mon, 17 Feb 2025 | HK$430.0b | HK$463.6b | HK$32.0b | 8.6x | 13.5x | 0.9x |
| Wed, 15 Jan 2025 | HK$402.8b | HK$458.9b | HK$31.7b | 8x | 12.7x | 0.9x |
| Fri, 13 Dec 2024 | HK$449.4b | HK$462.5b | HK$31.9b | 8.5x | 14.1x | 1x |
| Sun, 10 Nov 2024 | HK$445.9b | HK$467.8b | HK$32.4b | 8.5x | 13.7x | 1x |
| Tue, 08 Oct 2024 | HK$544.6b | HK$477.2b | HK$33.1b | 10.1x | 16.4x | 1.1x |
| Thu, 05 Sep 2024 | HK$437.5b | HK$472.8b | HK$32.8b | 7.8x | 13.3x | 0.9x |
| Sat, 03 Aug 2024 | HK$418.9b | HK$461.8b | HK$32.8b | 7.4x | 12.8x | 0.9x |
| Mon, 01 Jul 2024 | HK$438.9b | HK$461.3b | HK$33.7b | 8.2x | 13x | 1x |
| Wed, 29 May 2024 | HK$469.8b | HK$463.7b | HK$33.9b | 8.6x | 13.9x | 1x |
| Fri, 26 Apr 2024 | HK$452.4b | HK$464.0b | HK$33.8b | 7.5x | 13.4x | 1x |
| Sun, 24 Mar 2024 | HK$460.5b | HK$469.9b | HK$32.8b | 7.8x | 14x | 1x |
| Tue, 20 Feb 2024 | HK$429.0b | HK$470.8b | HK$33.6b | 7.4x | 12.8x | 0.9x |
| Thu, 18 Jan 2024 | HK$427.5b | HK$471.5b | HK$33.6b | 7.2x | 12.7x | 0.9x |
| Sat, 16 Dec 2023 | HK$489.8b | HK$473.3b | HK$33.9b | 8x | 14.4x | 1x |
| Mon, 13 Nov 2023 | HK$487.0b | HK$469.2b | HK$31.9b | 7x | 15.3x | 1x |
| Wed, 11 Oct 2023 | HK$426.5b | HK$469.4b | HK$31.6b | 6.7x | 13.5x | 0.9x |
| Fri, 08 Sep 2023 | HK$421.1b | HK$469.1b | HK$31.5b | 6.7x | 13.4x | 0.9x |
| Sun, 06 Aug 2023 | HK$471.8b | HK$446.7b | HK$27.9b | 9x | 16.9x | 1.1x |
| Tue, 04 Jul 2023 | HK$492.8b | HK$445.5b | HK$27.7b | 9.7x | 17.8x | 1.1x |
| Thu, 01 Jun 2023 | HK$506.3b | HK$448.7b | HK$27.9b | 8.6x | 18.1x | 1.1x |
| Sat, 29 Apr 2023 | HK$570.2b | HK$453.7b | HK$28.8b | 9x | 19.8x | 1.3x |
| Mon, 27 Mar 2023 | HK$543.3b | HK$444.4b | HK$33.9b | 8.7x | 16x | 1.2x |
| Wed, 22 Feb 2023 | HK$609.1b | HK$445.2b | HK$35.3b | 11.3x | 17.3x | 1.4x |
| Fri, 20 Jan 2023 | HK$628.4b | HK$447.3b | HK$35.6b | 10.5x | 17.7x | 1.4x |
| Sun, 18 Dec 2022 | HK$617.3b | HK$441.6b | HK$34.7b | 10.6x | 17.8x | 1.4x |
Price to Earnings Ratio
17.8x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 27.8x which is higher than its 3-year average PE of 16.9x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 5.0% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Hong Kong Pharma compare with similar industries?
| HK Market | -1.82% | |
| Healthcare | -0.76% | |
| Pharma | 1.86% | |
| Pharma | 1.86% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$42.52 | 5.8% +HK$14.2b | 128.6% | PE48.9x | |
| 2575 Xuanzhu Biopharmaceutical | HK$67.80 | 5.1% +HK$1.7b | n/a | PS997.4x | |
| 2096 Simcere Pharmaceutical Group | HK$13.75 | 5.0% +HK$1.7b | 95.0% | PE36.8x | |
| 1093 CSPC Pharmaceutical Group | HK$7.77 | 0.9% +HK$800.3m | 54.8% | PE19.9x | |
| 867 China Medical System Holdings | HK$13.61 | 2.5% +HK$797.5m | 79.6% | PE18.1x |
